Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: Role of prostaglandin E2 in RNA replication

Journal of Virology

Volumn 79, Issue 15, 2005, Pages 9725-9734

  Waris, Gulam ^a   Siddiqui, Aleem ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIOXIDANT; CALCIUM CHELATING AGENT; CALPASTATIN; CELECOXIB; CYCLOOXYGENASE 2; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN BAD; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CHRONIC LIVER DISEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; VIRUS EXPRESSION; VIRUS INFECTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CHELATING AGENTS; CYCLOOXYGENASE 2; DINOPROSTONE; GLYCOPROTEINS; HEPACIVIRUS; HUMANS; MEMBRANE PROTEINS; NF-KAPPA B; NITROBENZENES; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; PYRROLIDINES; REACTIVE OXYGEN SPECIES; REPLICON; RNA, VIRAL; SULFONAMIDES; THIOCARBAMATES;

HEPATITIS C VIRUS;

EID: 22544447811     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.15.9725-9734.2005     Document Type: Article

References (70)

1. Bae, S. H., E. S. Jung, Y. M. Park, B. S. Kim, B. K. Kim, D. G. Kim, and W. S. Ryu. 2001. Expression of cyclooxygenase-2 (Cox-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a Cox-2 inhibitor, NS-398. Clin. Cancer Res. 7:1410-1418.
2. Baldwin, A. S., Jr. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Investig. 107:241-246.
3. Barbieri, S. B., S. Eligini, M. Brambilla, E. Tremoli, and S. Colli. 2003. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc. Res. 60:187-197.
4. Bartenschlager, R., and V. Lohmann. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81:1631-1648.
5. Bartenschlager, R., and V. Lohmann. 2001. Novel cell culture systems for the hepatitis C virus. Antiviral Res. 52:1-17.
6. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
7. Caivano, M., B. Gorgoni, P. Cohen, and V. Poli. 2001. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J. Biol. Chem. 276:48693-48701.
8. Cantrell, D. A. 2001. Phosphoinositide 3-kinase signaling pathways. J. Cell Sci. 114:1439-1445.
9. Chan, G., J. O. Boyle, E. K. Young, F. Zhang, P. G. Sacks, J. P. Shah, D. Edelstein, R. A. Soslow, A. T. Koki, B. M. Woerner, J. L. Masferrer, and A. J. Dannenberg. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59:991-994.
10. Cheng, A. S., H. L. Chan, N. W. Leung, C. T. Liew, K. F. To, P. B. Lai, and J. J. Sung. 2002. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment. Pharmacol. Ther. 16:251-260.
11. Choi, J., K. J. Lee, Y. Zheng, A. K. Yamaga, M. M. C. Lai, and J. H. Ou. 2004. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39:81-89.
12. Cooray, S. 2004. The pivotal role of phosphotidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85:1065-1076.
13. Dempke, W., C. Rice, A. Grothey, and H. J. Schmoll. 2001. Cyclooxygenase-2: a novel target for cancer therapy. J. Cancer Res. Clin. Oncol. 127:411-417.
14. de Wet, J. R., K. V. Wood, M. Deluka, D. R. Helinski, and S. Subramaniam. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:723-737.
15. Di Bishceglie, A. M. 1997. Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S-38S.
16. Dubuisson, J., F. Penin, and D. Moradpour. 2002. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol. 12:517-523.
17. Eberhart, C. E., and R. N. DuBois. 1995. Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301.
18. Flory, E., M. Kunz, C. Scheller, C. Jassoy, R. Stauber, U. R. Rapp, and S. Ludwig. 2000. Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral protein and involves oxidative radicals and activation of IκB kinase. J. Biol. Chem. 275:8307-8314.
19. Flowers, M., A. Sherker, S. B. Sinclair, P. D. Greig, R. Cameron, M. J. Phillips, L. Blendis, S. W. Chung, and G. A. Levy. 1994. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation 58:183-192.
20. Gately, S. 2000. The contributions of cyclooxygenases-2 to tumor angiogenesis. Cancer Metastasis Rev. 19:19-27.
21. Gong, G., G. Waris, R. Tanveer, and A. Siddiqui. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc. Natl. Acad. Sci. USA 98:9599-9604.
22. Guo, J.-T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
23. Gupta, R. A., and R. N. DuBois. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer 1:11-21.
24. Hayes, M. M., B. R. Lane, S. R. King, D. M. Markovitz, and M. J. Coffey. 2002. Prostaglandin E2 inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell. Immunol. 215:61-71.
25. He, Y. P., H. H. Nakao, S. L. Tan, P. J. Polyak, P. Neddermann, S. Vijaysri, B. L. Jacobs, and M. G. Katze. 2002. Subversion of cell signaling pathways by hepatitis C virus nonstructural protein 5A protein via interaction with Grb2 and p85 phosphatidylinositol 3-kinase. J. Virol. 76:9207-9217.
26. Hsu, A. L., T. T. Ching, D. S. Wang, X. Song, V. M. Rangnekar, and C. S. Chen. 2000. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 275:11397-11403.
27. Hyman, A., C. Yim, M. Krajden, S. Read, A. S. Basinski, I. Wanless, G. Levy, and J. Heathcote. 1999. Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J. Viral Hepat. 6:329-336.
28. Iniguez, M. A., S. Martinez-Martinez, C. Punzon, J. M. Redondo, and M. Fresno. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol, Chem. 275:23627-23635.
29. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
30. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature 385:544-548.
31. Kern, M. A., D. Schubert, D. Sahi, M. M. Schoneweiss, I. Moll, A. M. Haugg, H. P. Dienes, K. Breuhahn, and P. Schirmacher. 2002. Proapoptotic and antiproliferative potential of selective cyclooxygenase inhibitors in human liver tumor cells. Hepatology 36:885-894.
32. Kiritoshi, S., T. Nishikawaj K. Sonoda, D. Kukidome, T. Senokuchi, T. Matsuo, T. Matsumura, H. Tokunaga, M. Brownlee, and E. Araki. 2003. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells. Diabetes 52:2570-2577.
33. Lara-Pezzi, E., M. V. Gomez-Gaviro, B. G. Galvez, E. Mira, M. A. Iniguez, M. Fresno, C. Martinez-A, A. G. Arroyo, and M. Lopez-Cabrera. 2002. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Investig. 110:1831-1838.
34. Leng, J., C. Han, A. J. Demetris, G. K. Michalopoulos, and T. Wu. 2003. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation: evidence for AKT inhibition in celecoxib-induced apoptosis. Hepatology 38:756-768.
35. Lohmann, V., F. Korner, J. O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
36. Lohmann, V., F. Korner, A. Dobierzewska, and R. Bartenschlager. 2001. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75:1437-1449.
37. Luczak, M., W. Gumulka, S. Szmigielski, and M. Korbecki. 1975. Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Arch. Virol. 49:377-380.
38. Mori, N., H. Inoue, T. Yoshida, T. Tanabe, and N. Yamamoto. 2001. Constitutive expression of the cyclooxygenase-2 gene in T-cell lines infected with human T cell leukemia virus type 1. Int. J. Cancer 94:813-819.
39. Muller, F. 1992. Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radic. Biol. Med. 13:651-657.
40. Ongradi, J., and A. Telekes. 1990. Relationship between the prostaglandin cascade and virus infection. Acta Virol. 34:380-400.
41. Ottonello, L., R. Gonella, P. Dapino, C. Sacchetti, and F. Dallegri. 1998. Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels. Exp. Hematol. 26:895-902.
42. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A view of prostaglandin E regulation of the immune response. Immunol. Today 12:349-352.
43. Rahman, M. A., D. K. Dhar, E. Yamaguchi, S. Maruyama, T. Sato, H. Hayashi, T. Ono, A. Yamanoi, H. Kohno, and N. Nagasue. 2001. Coexpression of inducible nitric oxide synthase and Cox-2 in hepatocellular carcinoma and surrounding liver: possible involvement of Cox-2 in the angiogenesis of hepatitis C virus-positive cases. Clin. Cancer Res. 7:1325-1332.
44. Sano, H., Y. Kawahito, R. L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:3785-3789.
45. Santro, M. G. 1997. Antiviral activity of cyclopentenone prostanoids. Trends Microbiol. 5:276-281.
46. Schreck, R., P. Rieber, and P. A. Baeurele. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-kB transcription factor and HIV. EMBO J. 10:2247-2258.
47. Shi, S. T., K. J. Lee, H. Aizaki, S. B. Hwang, and M. M. C. Lai. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77:4160-4168.
48. Steer, S. A., and J. A. Corbett. 2003. The role and regulation of Cox-2 during viral infection. Viral Immunol. 16:447-460.
49. Steer, S. A., J. M. Moran, L. B. Maggi, Jr., R. M. Buller, H. Perlman, and J. A. Corbett. 2003. Regulation of cyclooxygenase-2 expression by macrophages in response to double stranded RNA and viral infection. J. Immunol. 170:1070-1076.
50. Street, A., A. Macdonald, K. Crowder, and M. Harris. 2004. The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 279:12232-12241.
51. Sumitani, K., R. Kamijo, T. Toyoshima, Y. Nakanishi, K. Takizawa, M. Hatori, and M. Nagumo. 2001. Specific inhibition of cyclooxygenase-2 results in inhibition of oral cancer cell lines via suppression of prostaglandin E2 production. J. Oral Pathol. Med. 30:41-47.
52. Sun, Y. 1990. Free radicals, anti-oxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8:583-599.
53. Symensma, T. L., D. Martinez-Guzman, Q. Jia, E. Bortz, T. T. Wu, N. R. Ganguly, S. Cole, H. Herschman, and R. Sun. 2003. Cox-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J. Virol. 77:12753-12763.
54. Tai, D. I., S. L. Tsai, Y. H. Chang, S. N. Huang, T. C. Chen, K. S. Chang, and Y. F. Liaw. 2000. Constitutive activation of nuclear factor kappa B in hepatocellular carcinoma. Cancer 89:2274-2281.
55. Tanaka, T., N. Kato, M. J. Cho, and K. Shimotohno. 1995. A novel sequence found at the 3′ terminus of the hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:744-749.
56. Tardif, K. D., K. Mon, and A. Siddiqui. 2002. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol. 76:7453-7459.
57. Tardiff, K. D., G. Waris, and A. Siddiqui. 2005. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 13:159-163.
58. Tsujii, M., and R. N. DuBois. 1995. Alteration in cell adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83:493-501.
59. Thivierge, M., C. le Guoill, M. J. Tremblay, J. Stankova, and M. Rola-Pleszczynski. 1998. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92:40-45.
60. Uefuji, K., T. Ichikura, H. Mochizuki, and N. Shinomiya. 1998. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surg. Oncol. 69:168-172.
61. Waris, G., K. D. Tardif, and A. Siddiqui. 2002. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-κB and STAT-3. Biochem. Pharmacol. 64:1425-1430.
62. Waris, G., A. Livolsi, V. Imbert, J. F. Peyron, and A. Siddiqui. 2003. Hepatitis C virus NS5A protein and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J. Biol. Chem. 278:40778-40787.
63. Waris, G., S. Sarker, and A. Siddiqui. 2004. Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA 10:321-329.
64. Waris, G., J. Turkson, T. Hassanein, and A. Siddiqui. 2005. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J. Virol. 79:1569-1580.
65. Williams, C. S., M. Mann, and R. N. DuBois. 1999. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908-7916.
66. Williams, C. S., A. J. Watson, H. Sheng, R. Helou, J. Shao, and R. N. DuBois. 2000. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res. 60:6045-6051.
67. Xu, X. C. 2002. Cox-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127-137.
68. Xu, Z., J. T. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindrajan, D. Chien, M. Silby, and J. Ou. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840-3848.
69. Yip-Schneider, M. T., D. S. Barnard, S. D. Billings, L. Cheng, D. K. Bellman, A. Lin, S. J. Marshall, P. L. Crowell, M. S. Marshall, and C. J. Sweeney. 2000. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (London) 21:139-146.
70. Zhu, H., J. P. Cong, D. Yu, W. A. Bresnahan, and T. E. Shenk. 2002. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. USA 99:3932-3937.